Concepedia

Anahí Yañez

AY

Statistics

Publications

2

Citations

323

H-Index

2

Active since

2018

Affiliations

AstraZeneca (Sweden)(Current)

Vancouver General Hospital

Medical University of Lodz

Physiologie et Médecine Expérimentale du Coeur et des Muscles

University of British Columbia

Anahí Yañez is an author at AstraZeneca (Sweden) specializing in immunotherapy, asthma pharmacotherapy, and asthma management.

Publications per year

2018–2025

2

Publications

2

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

, , +6

Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World Data

Wenjia Chen, Trung N. Tran, John Townend et al. · The Journal of Allergy and Clinical Immunology In Practice · 2025 · 12 citations · Full text

, , +14

1–2 of 2